TCI Wealth Advisors’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5
| Closed | -$441 | – | 2015 |
|
|
2023
Q1 | $441 | Hold |
5
| – | – | ﹤0.01% | 2236 |
|
|
2022
Q4 | $454 | Hold |
5
| – | – | ﹤0.01% | 2225 |
|
|
2022
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 2163 |
|
|
2022
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 2209 |
|
|
2022
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 2445 |
|
|
2021
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 2238 |
|
|
2021
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 2310 |
|
|
2021
Q2 | $2K | Hold |
5
| – | – | ﹤0.01% | 2097 |
|
|
2021
Q1 | $3K | Sell |
5
-2
| -29% | -$1.25K | ﹤0.01% | 1593 |
|
|
2020
Q4 | $3K | Sell |
7
-2
| -22% | -$795 | ﹤0.01% | 1140 |
|
|
2020
Q3 | $3K | Hold |
9
| – | – | ﹤0.01% | 1008 |
|
|
2020
Q2 | $4K | Hold |
9
| – | – | ﹤0.01% | 841 |
|
|
2020
Q1 | $3K | Sell |
9
-5
| -36% | -$2.59K | ﹤0.01% | 926 |
|
|
2019
Q4 | $10K | Buy |
14
+1
| +8% | +$688 | ﹤0.01% | 711 |
|
|
2019
Q3 | $9K | Hold |
13
| – | – | ﹤0.01% | 675 |
|
|
2019
Q2 | $12K | Sell |
13
-4
| -24% | -$2.75K | 0.01% | 591 |
|
|
2019
Q1 | $10K | Buy |
17
+3
| +21% | +$1.25K | ﹤0.01% | 637 |
|
|
2018
Q4 | $4K | Sell |
14
-3
| -18% | -$1.19K | ﹤0.01% | 847 |
|
|
2018
Q3 | $8K | Sell |
17
-4
| -19% | -$1.72K | ﹤0.01% | 699 |
|
|
2018
Q2 | $9K | Sell |
21
-6
| -22% | -$3.81K | ﹤0.01% | 660 |
|
|
2018
Q1 | $16K | Sell |
27
-8
| -23% | -$4.99K | 0.01% | 532 |
|
|
2017
Q4 | $22K | Sell |
35
-6
| -15% | -$4.31K | 0.01% | 481 |
|
|
2017
Q3 | $38K | Sell |
41
-5
| -11% | -$4.44K | 0.02% | 350 |
|
|
2017
Q2 | $43K | Sell |
46
-3
| -6% | -$2.94K | 0.02% | 334 |
|
|
2017
Q1 | $46K | Hold |
49
| – | – | 0.02% | 314 |
|
|
2016
Q4 | $39K | Hold |
49
| – | – | 0.02% | 365 |
|
|
2016
Q3 | $41K | Buy |
49
+4
| +9% | +$3.21K | 0.02% | 327 |
|
|
2016
Q2 | $37K | Buy |
45
+1
| +2% | +$1.09K | 0.02% | 331 |
|
|
2016
Q1 | $49K | Buy |
44
+5
| +13% | +$5.12K | 0.03% | 304 |
|
|
2015
Q4 | $48K | Buy |
39
+2
| +5% | +$3.31K | 0.03% | 310 |
|
|
2015
Q3 | $50K | Buy |
37
+6
| +19% | +$9.9K | 0.03% | 286 |
|
|
2015
Q2 | $56K | Buy |
31
+8
| +35% | +$12.4K | 0.03% | 271 |
|
|
2015
Q1 | $38K | Buy |
+23
| New | +$34.1K | 0.02% | 265 |
|
Other funds holding TCRT
DCM
MP
LCM
BC
GCP
TCI Wealth Advisors's TCRT Position: Q2 2023 in Review
TCI Wealth Advisors sold out of Alaunos Therapeutics (TCRT) in Q2 2023, closing a stake of 5 shares — an estimated $441 sold.
TCI Wealth Advisors first reported a position in TCRT in Q1 2015 and held it in 33 quarters. The position peaked at $56K in Q2 2015. 100 funds tracked by Wall St. Rank hold TCRT as of Q2 2023.
- TCI Wealth Advisors reported no remaining Alaunos Therapeutics position as of Q2 2023 after selling out during the quarter.
- TCI Wealth Advisors sold 5 Alaunos Therapeutics shares in Q2 2023, an estimated $441.
- TCI Wealth Advisors first reported a position in Alaunos Therapeutics in Q1 2015 and held it in 33 quarters.
- TCI Wealth Advisors's Alaunos Therapeutics position peaked at $56K in Q2 2015.
- 100 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2023.
Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.